Concord Drugs Ltd share price logo

Concord Drugs Share Price

BSE: 538965

Small Cap

Healthcare Sector

₹79.89

-0.82

(-1.02%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Concord Drugs Stock Performance

as on February 6, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹77.90
    ₹80.80
    downward going graph

    2.49%

    Downside

    1.14%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹26.10
    ₹92.52
    downward going graph

    67.33%

    Downside

    15.81%

    Upside

    downward going graph

Concord Drugs share price movements today

Previous Close
₹80.71
Open
₹80.72
Volume
3,660.00
Upper Circuit
₹84.74
Lower Circuit
₹76.68
Day's Low - High
₹77.90 - ₹80.80
52 Week Low - High
₹26.10 - ₹92.52

Concord Drugs Historical Returns

1 Month Return
-13.39 %
3 Month Return
+ 10.37 %
1 Year Return
+ 120.4 %
3 Year Return
+ 152.08 %
5 Year Return
+ 212.08 %

Concord Drugs Fundamentals

as on February 6, 2026 at 4:01 pm IST

Market Cap

₹78.02 Cr

Return on Equity (ROE)

0.88

PE Ratio (TTM)

134.52

Return on capital employed (ROCE)

4.49

Industry PE ratio

40.88

Beta (LTM)

0

P/B Ratio

0.91

Dividend Yield

0

PEG Ratio

123.41

Quarterly Earnings Growth YOY

375

EPS (TTM)

0.34

Sector

Pharmaceuticals

Book Value

34.11

Concord Drugs Stock Valuation

as on February 6, 2026 at 4:01 pm IST

Concord Drugs in the last 5 years

  • Overview

  • Trends

Lowest (-961.50x)

January 3, 2025

Industry (40.88x)

February 6, 2026

Today (134.52x)

February 6, 2026

Highest (791.40x)

July 3, 2024

LowHigh

Today’s Price to Earnings Ratio: 134.52x

Concord Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Concord Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Concord Drugs Ltd image
Concord Drugs Ltd
NA78.0242.42%0.70145
Venus Remedies Ltd image
Venus Remedies Ltd
NA981.7462.11%0.5045647
Parmax Pharma Ltd image
Parmax Pharma Ltd
NA12.441.49%0.00-328
Strides Pharma Science Ltd image
Strides Pharma Science Ltd
BUY7,962.800.61%0.723,5974,565
Cian Healthcare Ltd image
Cian Healthcare Ltd
NA12.52-11.05%0.82-2630
See all

Concord Drugs Share Price Target

Get share price movements and forecasts by analysts on Concord Drugs.

Source: S&P Global Market Intelligence

Concord Drugs Stock’s Investor Sentiment and Interest

Search interest for Concord Drugs Ltd Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Concord Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
12.31
8.98
7.52
12.78
15.64
11.69
12.36
10.8
10.39
13.61
10.28
Total Income
12.31
8.98
7.52
12.78
15.64
11.69
12.37
10.8
10.4
13.61
10.28
Expenses
11.34
7.52
5.91
12.15
15.29
10.86
11.49
9.41
9.35
12.59
9.18
Operating Profit
0.97
1.46
1.61
0.63
0.35
0.83
0.87
1.39
1.04
1.02
1.1
Operating Profit Margin %
7.88%
16.26%
21.41%
4.93%
2.24%
7.1%
7.04%
12.87%
10.01%
7.49%
10.7%
Profit Before Interest, Tax and Depreciation
0.97
1.46
1.61
0.63
0.35
0.83
0.88
1.39
1.05
1.02
1.1
Interest
0.5
0.44
0.43
0.5
0.5
0.45
0.47
0.5
0.61
0.49
0.49
Depreciation
0.33
0.38
0.39
0.39
0.39
0.34
0.34
0.37
0.38
0.37
0.34
Profit Before Tax
0.14
0.64
0.79
-0.26
-0.54
0.04
0.07
0.52
0.06
0.16
0.27
Tax Paid
-0.03
0.15
0.24
-0.01
-0.21
0.02
0.03
0.31
0.02
0.04
0.08
Profit After Tax
0.16
0.49
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Total Net profit including share of profit / Loss from associate company
0.16
0.49
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Actual EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Adjusted EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Diluted EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19

Concord Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
58.96
52.08
44.92
45.24
Total Income
59.06
52.09
44.93
45.26
Expenses
53.36
47.51
40.88
41.11
Operating Profit
5.6
4.57
4.04
4.13
Operating Profit Margin %
9.5%
8.77%
8.99%
9.13%
Profit Before Interest, Tax and Depreciation
5.69
4.58
4.05
4.15
Interest
1.68
1.71
1.87
2.03
Depreciation
1.76
1.63
1.56
1.43
Profit Before Tax
2.25
1.24
0.62
0.69
Tax Paid
0.65
0.26
0.16
0.35
Profit After Tax
1.59
0.99
0.47
0.34
Total Net profit including share of profit / Loss from associate company
1.59
0.99
0.47
0.34
EPS
1.82
1.06
0.47
0.34
Actual EPS
1.82
1.06
0.47
0.34
Adjusted EPS
1.82
1.06
0.47
0.34
Diluted EPS
1.82
1.06
0.47
0.34

Concord Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.77
1.66
0.79
3.72
Cash Flow from Investing Activities
0.01
-1.41
0.01
0.01
Cash Flow from Financing Activities
1.68
0.62
0.27
-1.43
Net Cash Flow
0.01
0.02
0.07
-0.02

Concord Drugs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
52.13%
52.13%
52.13%
55.41%
55.41%
55.41%
55.41%
54.39%
54.39%
54.39%
54.39%
54.39%
54.39%
Public
47.87%
47.87%
47.87%
44.59%
44.59%
44.59%
44.59%
45.61%
45.61%
45.61%
45.61%
45.61%
45.61%
Total Outstanding Shares
93,15,470
93,15,470
93,15,470
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
Total Shareholders
3,204
3,198
3,957
3,963
4,032
4,734
4,755
5,073
5,073
5,252
5,189
4,718
4,718

Concord Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Concord Drugs.

  • Concord Drugs Ltd Earnings Results

    Concord Drugs Ltd’s net profit jumped 375% since last year same period to ₹0.19Cr in the Q2 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 58.33% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Concord Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Concord Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, Concord Drugs stock has moved up by 39.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 0.04 Cr → 0.19 Cr (in ₹), with an average increase of 51.8% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 45.61% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.39% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 156.4% return, outperforming this stock by 4.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 13.61 Cr → 10.28 Cr (in ₹), with an average decrease of 24.5% per quarter

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is one of the most reputable pharmaceutical companies in India that manufactures Finished Pharmaceutical Formulations such as Injectables, Small Volume Parenterals, Dry Powder, Tissue BioAdhesive Tablets, Capsules and Ophthalmic Preparations, and Readytofill Pellets. They specialize in cGMP contract manufacturing and FormulationFillFinish facility providing comprehensive pharmaceutical development and manufacturing services for drug products. Through the use of state-of-the-art technology that ensures the highest level of process integrity and product quality, they strive to provide their customers with an end-to-end solution to their various pharmaceutical product needs. In order to meet the standards set by regulatory bodies, their two manufacturing facilities are designed to comply with the prerequisites of these governing bodies.

Revenue: ₹10.28Cr as on September 2025 (Q2 FY26)
Net Profit: ₹0.19Cr as on September 2025 (Q2 FY26)
Chairperson Name: S Nagi Reddy
OrganisationConcord Drugs Ltd
IndustryPharmaceuticals
CEOS Nagi Reddy
E-voting on sharesClick here to vote

FAQs

What is Concord Drugs share price today?

Concord Drugs share price today stands at ₹79.89 as on at the close of the market. Concord Drugs share today touched a day high of ₹80.8 and a low of ₹77.9.

What is the 52 week high and 52 week low range for Concord Drugs share?

Concord Drugs touched a 52 week high of ₹92.52 and a 52 week low of ₹26.1. Concord Drugs share price today i.e. is closed at ₹79.89, which is -13.65% down from its 52 week high and 206.09% up from its 52 week low.

What is Concord Drugs's market capitalisation today?

Concord Drugs market capitalisation is ₹78.02 Cr as on .

How to buy Concord Drugs shares?

To buy Concord Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 538965 or Concord Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Concord Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Concord Drugs trading volume today?

Concord Drugs trading volume is 3,660.00 as on . This means that 3,660.00 shares of Concord Drugs were bought and sold on the stock market during today's trading session.